XMR

XMReality

Market Cap 132.2M

XMReality has developed and offered augmented reality solutions since 2007. The company is offering software and hardware for remote guidance towards field service companies where clients either implement the solution throughout their internal service organization or in their service offering towards clients.

+ more
Today
Day High
9.90
9.05
Day Low
8.90
Day Open
9.60
Prev Close
9.87
VWAP
9.2
Volume
100K
Turnover
0.920M
Top Broker
VWAP
9.3
Avg Volume
25K
Avg Turnover
0.233M
Top Brokers
AVA/MLI
VWAP
9.4
Avg Volume
17K
Avg Turnover
0.158M
Top Brokers
AVA/MLI
VWAP
9.6
Avg Volume
19K
Avg Turnover
0.184M
Top Brokers
AVA/NON
52 week summary
Price Range
6.2
Last
12.1
Beta
N/A
Market Cap
132.2M
Total Return
-17.1%
Trailing P/E
-6.3
Div Yield
0.0%
Shares Outstanding
14.6M
Stock Exchange
First North Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.

Relative Price Strength
Change 3 Months 30.1%
Change 12 Months -27.8%
Volume Trend
Average Volume 10 vs 60 Days -45.6%
Price VS
52 Week High -24.9%
50 Day Moving Average 3.3%
200 Day moving Average 19.1%

Add article markers

Compare XMReality to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
Last updated: 2018-02-22 Source: Redeye
Major Owners Equity Votes
Handelsbanken Fonder 8.4%
8.4%
AMF Försäkring & Fonder 7.5%
7.5%
ALMI 6.9%
6.9%
Lars Svensson 5.7%
5.7%
Torbjörn Gustafsson 5.5%
5.5%
Per Carleberg 5.5%
5.5%
Avanza Pension 4.2%
4.2%
Claes Nylander 3.8%
3.8%
C WorldWide Asset Management 3.3%
3.3%
Jens Miöen 2.6%
2.6%
Last updated: 2018-04-19 Source: Redeye/Holdings
Timeframe Transactions Net Shares
Last 12 weeks
0 Purchases
0
0 Sales
0
Last 24 weeks
0 Purchases
0
0 Sales
0
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Insider trades are behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Millistream
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow
  • 2015
  •  
  • -126.2%
  • -72.6%
  • -175.9%
  • -118.8%
  • -118.8%
  • -121.1%
  •  
  • 0.00
  • 0.00
  • 0.00
  •  
  • 0.0
  •  
  • 3.1
  • 0.0
  • 0.0
  • 0.0
  • 0.9
  • -0.7
  • -0.7
  • 0.0
  •  
  • 30.6%
  • 100.0%
  • 3
  • 6
  • 0.4
  • 2015
  •  
  •  
  • 1
  • 2
  • 2
  • 0
  • 4
  •  
  • 0
  • 0
  • 0
  • 0
  • 0
  • 5
  • 0
  • 5
  • 0
  • 9
  •  
  •  
  • 0
  • 2
  • 0
  • 2
  • 4
  • 0
  • 0
  • 6
  • 0
  • 0
  • 3
  • 0
  • 3
  • 9
  • 2015
  • 4
  • -8
  • 0
  • -4
  • 0
  • -4
  • 0
  • -4
  • -1
  • -2
  • -8
  • 2015 Q3
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 2015 Q4
  • 4
  • -8
  • -4
  • 0
  • 0
  • 0
  • -4
  • 0
  • 0
  • 0
  • -4
  • 0
  • -4
  • 2016
  •  
  • -68.5%
  • -55.0%
  • -170.5%
  • -174.2%
  • -193.6%
  • -194.8%
  •  
  • -1.20
  • -1.20
  • 0.00
  •  
  • 8.4
  •  
  • -19.4
  • 0.0
  • 0.0
  • 0.0
  • -3.8
  • 2.2
  • 1.9
  • 0.0
  •  
  • 81.7%
  • 100.0%
  • -19
  • 7
  • 0.2
  • 2016
  •  
  •  
  • 22
  • 2
  • 1
  • 0
  • 25
  •  
  • 1
  • 0
  • 0
  • 0
  • 0
  • 7
  • 0
  • 8
  • 0
  • 33
  •  
  •  
  • 0
  • 3
  • 0
  • 4
  • 2
  • 0
  • 0
  • 6
  • 0
  • 0
  • 27
  • 0
  • 27
  • 33
  • 2016
  • 5
  • -14
  • -1
  • -10
  • 0
  • -10
  • 1
  • -9
  • 2
  • -4
  • -11
  • 2016 Q1
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 2016 Q2
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 2016 Q3
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 2016 Q4
  • 5
  • -14
  • -9
  • -1
  • 0
  • 0
  • -10
  • 0
  • 0
  • 0
  • -10
  • 0
  • -10
  • 2017
  •  
  • -54.6%
  • -51.3%
  • -319.5%
  • -309.8%
  • -338.7%
  • -340.3%
  •  
  • -1.56
  • -1.56
  • 0.00
  •  
  • 14.6
  •  
  • 107.9
  • -6.7
  • -6.7
  • 22.7
  • 16.2
  • -5.2
  • -4.8
  • 2.7
  •  
  • 85.6%
  • 1.5%
  • -44
  • 13
  • 0.1
  • 2017
  •  
  •  
  • 46
  • 6
  • 0
  • 0
  • 52
  •  
  • 2
  • 0
  • 0
  • 0
  • 0
  • 12
  • 0
  • 14
  • 0
  • 66
  •  
  •  
  • 1
  • 7
  • 0
  • 8
  • 2
  • 0
  • 0
  • 10
  • 0
  • 0
  • 57
  • 0
  • 57
  • 66
  • 2017
  • 7
  • -27
  • -2
  • -23
  • 0
  • -23
  • 2
  • -21
  • 1
  • -9
  • 24
  • 2017 Q1
  • 1
  • -5
  • -4
  • 0
  • 0
  • 0
  • -4
  • 0
  • 0
  • 0
  • -4
  • 0
  • -4
  • 2017 Q2
  • 1
  • -6
  • -5
  • 0
  • 0
  • 0
  • -5
  • 0
  • 0
  • 0
  • -5
  • 0
  • -5
  • 2017 Q3
  • 2
  • -6
  • -5
  • -1
  • 0
  • 0
  • -5
  • 0
  • 0
  • 0
  • -5
  • 0
  • -5
  • 2017 Q4
  • 3
  • -10
  • -7
  • -1
  • 0
  • 0
  • -8
  • 0
  • 0
  • 0
  • -8
  • 0
  • -8
  • 2018 E
  • 2018 E
  • 2018 E
  • 2018 E
  • 2019 E
  • 2019 E
  • 2019 E
  • 2019 E
  • 2020 E
  • 2020 E
  • 2020 E
  • 2020 E

Estimated Values are behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Last updated: 2018-08-14 Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.

Source: Redeye

Community Posts

Be the first to write something about this company in the community.

Create new post